Success Stories: Advancing U.S. Cardiology—How a Research-Driven Physician from Bangladesh Secured NIW Approval

Client’s Testimonial:

“Victoria Chen and her team have managed to make a complicated, drawn-out and difficult process such as the EB2-NIW application seem easy, smooth and straightforward, and I can think of no higher praise than that. I am grateful to have had a chance to work with you. You have lived up to every bit of your stellar reputation. I am very grateful for your guidance and wisdom throughout this process.”

On June 12^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a physician-scientist in the field of cardiology (Approval Notice).

General Field: Cardiology

Position at the Time of Case Filing: Interventional Cardiology Fellow

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: June 12^th, 2025

Processing Time: 1 month, 19 days (Premium Processing Requested)

Case Summary:

We are pleased to announce the approval of an NIW petition filed on behalf of a Bangladeshi physician and researcher specializing in cardiology. This client’s proposed endeavor to develop medications, tools, and techniques to mitigate the onset and progression of atherosclerosis and heart failure was recognized for its substantial merit and national importance. His research spans both innovative clinical applications and collaborative industry efforts, all focused on enhancing cardiovascular health outcomes in the United States.

Innovative Cardiovascular Research Driving National Health

The client’s research addresses some of the most pressing challenges in cardiovascular care, including catheter-device-related infections, diuretic resistance, and catastrophic antiphospholipid syndrome. Through original studies and clinical insight, his work contributes to more effective diagnostics, therapeutic tools, and treatment strategies aimed at reducing the burden of cardiovascular disease.

Scholarly Productivity and Impact

With 16 peer-reviewed journal articles and 22 conference abstracts, the client has consistently produced impactful research. His work has been cited over 330 times, and at least six of his papers rank among the top 10–20% most cited in clinical medicine for their publication years. These metrics reflect both scholarly recognition and real-world influence.

In addition to his publication record, the client has also served as a peer reviewer for several academic journals, further demonstrating his standing within the research community.

Strategic Case Framing

To establish eligibility for the National Interest Waiver, our legal team emphasized the national importance of the client’s work and his strong positioning to advance his research objectives. We supported the petition with letters from respected experts and documented how his innovations aligned with U.S. public health and economic interests, particularly in combating heart failure and atherosclerosis, which remain among the leading causes of mortality and healthcare expenditure in the United States.

His case was further supported by the signed recommendation letters from his fellow peers, one of which is mentioned below:

“Given that cardiovascular disease remains the leading cause of mortality in the U.S., [client’s] improvements to both treatment efficacy and procedural safety are essential for addressing critical public health priorities.”

Continued Impact on U.S. Healthcare

Now approved under EB-2 NIW, our client is set to continue his work in cardiovascular research and patient care. His commitment to advancing clinical outcomes through innovation and interdisciplinary collaboration positions him to make enduring contributions to the American healthcare system. NAILG is proud to have played a role in this important success.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.